Photo: Operating room at Innovative Vascular Institute, San Antonio, TX.
On Friday, the Mayo Clinic Board of Trustees elected Dr. Matthew Callstrom, a body interventional radiologist and the architect of Mayo's AI strategy, as its next president and CEO. For a specialty that has spent decades explaining itself at cocktail parties, that is a big deal.
4 min read
Interventional radiology has a familiar problem. Ask the average person what an IR doctor does and you will get a shrug, or a guess involving X-rays. Ask a hospital board, and until recently you might have gotten the same shrug. That changed on Friday, November 13, when the Mayo Clinic Board of Trustees announced that Dr. Matthew R. Callstrom will become president and CEO of the entire Mayo enterprise on January 1, 2027. [1][2]
Callstrom is not a cardiologist, a surgeon, or a career administrator. He is a physician-scientist who built his reputation threading needles into tumors under image guidance. [1][3]
What the new boss actually does
For those outside the catheter lab: interventional radiologists use CT, ultrasound, and fluoroscopy to treat disease through pinhole incisions instead of open surgery. Callstrom's corner of that world is interventional oncology, the use of those tools to freeze, burn, or otherwise destroy cancers in the liver, kidney, lung, bone, and soft tissue. [3]
His Mayo faculty page lists clinical trials testing whether cryoablation can relieve pain from bone metastases after other treatments have failed, how it stacks up against radiation, and whether ablation can provoke the immune system into attacking melanoma elsewhere in the body. He has also worked on image fusion, which overlays a patient's earlier CT, MRI, or PET scans onto live ultrasound so the needle goes exactly where the tumor is. [3]
He holds more than 200 publications and patents, has served as president of the Society of Interventional Oncology, and was named a Mayo Clinic Distinguished Clinician. [1]
The résumé behind the résumé
Callstrom grew up in Minnesota and graduated from Albert Lea High School in 1979. He earned degrees in chemical engineering and chemistry at the University of Minnesota, did a postdoctoral fellowship at Harvard, then came back to Rochester for medical school, a radiology residency, and a cross-sectional imaging fellowship. He joined the Mayo staff in 2002. [1][4]
Inside Mayo he has chaired the Department of Radiology in Rochester, served as interim chief strategy officer, and most recently run both the Strategy Department and the institution's AI program, which Becker's described as the reason the board picked him. [1][2]
He succeeds Dr. Gianrico Farrugia, a gastroenterologist who has led Mayo since 2019 and announced in May that he would step down at year's end. Farrugia leaves behind the "Bold. Forward." strategy, the Mayo Clinic Platform, and a $5 billion rebuild of the downtown Rochester campus. Mayo employs roughly 85,000 people and reported about $21.5 billion in revenue in 2025, so this is not a small clinic changing its letterhead. [2][5]
Why the specialty is quietly thrilled
Here is the opinion part, and it is opinion: IR has long been medicine's most useful department that nobody can find on the directory. Its doctors treat strokes, stop bleeding, open blocked leg arteries, drain abscesses, and ablate tumors, often without an admission. Yet IR has rarely had a seat at the table where hospital strategy gets decided.
Putting an interventional oncologist in charge of the most famous medical brand in America is a signal that minimally invasive, image-guided care is no longer a side room off the surgery department. It is the plan.
The AI piece matters too. Callstrom's day job for the past several years has been figuring out how Mayo uses artificial intelligence responsibly, with a stated goal of detecting disease earlier. Whether that translates into better care or just better dashboards is the question every health system is now facing, and Mayo just made its AI lead the person who answers for it.
A note of healthy skepticism
Board statements are, by design, cheerful. Richard Davis, the board chair, praised Callstrom's ability to see what is coming next, and Callstrom said he is honored to lead Mayo in this moment. [1] That is exactly what everyone says on day one.
The harder test comes later: whether a scientist who has spent 25 years inside one institution can steer it through a year of Medicare cuts, Medicaid uncertainty, and a brutal labor market, while keeping Mayo's first principle, that the needs of the patient come first, from becoming a slogan. [2]
Still, for a specialty that spends a lot of its time explaining it is not "just radiology," Friday was a good day. The next CEO of Mayo Clinic knows how to place a cryoprobe. That has never been true before.
References
Mayo Clinic News Network, "Mayo Clinic Board of Trustees elects Matthew R. Callstrom, M.D., Ph.D., as next president and CEO," Nov. 13, 2026. https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-board-of-trustees-elects-matthew-r-callstrom-m-d-ph-d-as-next-president-and-ceo/
Becker's Hospital Review, "Mayo Clinic appoints AI leader as next CEO," Nov. 13, 2026. https://www.beckershospitalreview.com/hospital-executive-moves/mayo-clinic-appoints-ai-leader-as-next-ceo/
Mayo Clinic Research faculty profile, Matthew R. Callstrom, M.D., Ph.D. https://www.mayo.edu/research/faculty/callstrom-matthew-r-m-d-ph-d/bio-00085927
Albert Lea Tribune via Yahoo News, "Mayo Clinic Board of Trustees elects Albert Lea alum as next president and CEO," Nov. 2026. https://www.yahoo.com/news/us/articles/mayo-clinic-board-trustees-elects-004800292.html
Fierce Healthcare, "Mayo Clinic CEO Gianrico Farrugia stepping down at year's end," May 2026. https://www.fiercehealthcare.com/providers/mayo-clinic-ceo-gianrico-farrugia-stepping-down-years-end
MPR News, "Mayo Clinic announces next CEO: Dr. Matthew Callstrom," Nov. 13, 2026. https://www.mprnews.org/story/2026/11/13/mayo-clinic-announces-next-ceo-dr-matthew-callstrom